MRE11A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.762800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.639600E-01
Normal-vs-Stage2
4.950400E-01
Normal-vs-Stage3
2.553200E-01
Normal-vs-Stage4
6.983200E-01
Stage1-vs-Stage2
6.893800E-01
Stage1-vs-Stage3
8.550100E-02
Stage1-vs-Stage4
5.949000E-01
Stage2-vs-Stage3
2.440000E-03
Stage2-vs-Stage4
2.950000E-01
Stage3-vs-Stage4
9.638000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.763800E-01
Normal-vs-AfricanAmerican
4.929600E-01
Normal-vs-Asian
3.756800E-01
Caucasian-vs-AfricanAmerican
4.426000E-01
Caucasian-vs-Asian
2.904200E-01
AfricanAmerican-vs-Asian
1.584160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.739000E-01
Normal-vs-Female
1.139190E-01
Male-vs-Female
8.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.676000E-01
Normal-vs-Age(41-60Yrs)
5.463600E-01
Normal-vs-Age(61-80Yrs)
4.448200E-01
Normal-vs-Age(81-100Yrs)
2.457000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.386600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.605600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.892400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.175010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.504400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.015600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.426400E-01
Normal-vs-Daily Drinker
2.179800E-01
Normal-vs-Weekly Drinker
4.122200E-01
Normal-vs-Occasional Drinker
4.896400E-01
Normal-vs-Social Drinker
5.691800E-01
Non Drinker-vs-Daily Drinker
8.315400E-01
Non Drinker-vs-Weekly Drinker
6.096200E-01
Non Drinker-vs-Occasional Drinker
8.359600E-01
Non Drinker-vs-Social Drinker
4.426400E-01
Daily Drinker-vs-Weekly Drinker
8.192000E-01
Daily Drinker-vs-Occasional Drinker
7.045000E-01
Daily Drinker-vs-Social Drinker
4.308400E-01
Weekly Drinker-vs-Occasional Drinker
4.458600E-01
Weekly Drinker-vs-Social Drinker
2.126800E-01
Occasional Drinker-vs-Social Drinker
5.327400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.162000E-01
Normal-vs-Grade 2
4.982300E-02
Normal-vs-Grade 3
8.098400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.723820E-02
Grade 1-vs-Grade 3
1.564430E-03
Grade 1-vs-Grade 4
3.162000E-01
Grade 2-vs-Grade 3
2.970300E-02
Grade 2-vs-Grade 4
4.982300E-02
Grade 3-vs-Grade 4
8.098400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.370400E-01
Normal-vs-NonDiabetic
4.465400E-01
Diabetic-vs-NonDiabetic
8.603000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.691200E-01
Normal-vs-NoPancreatitis
4.547000E-01
Pancreatitis-vs-NoPancreatitis
9.395600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.690400E-01
Normal-vs-N1
4.937000E-01
N0-vs-N1
6.805600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.365400E-01
Normal-vs-TP53-NonMutant
4.669800E-01
TP53-Mutant-vs-TP53-NonMutant
4.781800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
